Clinical trials to identify a safe and effective vaccine for COVID-19 (SARS-CoV-2) are presently underway. Upon completion, an all-consuming, simultaneous worldwide demand is bound to follow. How should a limited supply of vaccines be fairly allocated? Which ethical values should guide these decisions? How can apparent clashes between different ethical values be mitigated?
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023